GFAP and stroke disorder: Its presence in bodily fluids such as serum and cerebrospinal fluid sparks hope for its utility in early stroke diagnosis. GFAP has demonstrated high specificity (up to 85-95%) for distinguishing ischemic strokes from hemorrhagic strokes due to its release following astrocyte damage, which is more pronounced in hemorrhagic strokes.